Rabeya Yousuf

ADDRESSING RATIONAL PRESCRIBER S THROUGH THE PHARMACOLOGY AND THERAPEUTIC S COURSE WORK OF MBBS SYLLABUS IN BANGLADESH

Pharmacology is most rapidly expanding science in medical discipline which leads to the development of many important drugs to treat many medical conditions that was previously untreat able . This paper focuses on the necessity of integration of pharmacology in the medical curriculum in all clinical phases and ethical aspect s of medicine in terms of irrational prescribing. Irrational prescribing of drugs is a major global health problem i n medical practice. Currently Pharmacology is taught at phase - II, a 2 year period in a 5 years undergraduate medical Programme in Bangladesh under the name ‘Pharmacology and Therapeutics’. Indiscriminate use of clinically inappropriate and ineffective medi cines are a serious problem. Medicines in Bangladesh are inappropriately prescribed, again all kinds of drugs including controlled product s are dispensed and sold out frequently without prescription. Henceforth there are regular violation of medical ethics and professionalism. As only pharmacology and therapeutics deals with the correct selection of drugs, the subject should be continued to teach up to phase - III. In addition , therapeutic discussion should be incorporated with proper logbook during internshi p in order to make safe and efficient prescribers. Supreme priority should be given to legal and ethical aspects of medicine. Medical professionals must uphold social order by ensuring

Anti-G with concomitant anti-C and anti-D: A case report in a pregnant woman

The G antigen of Rh blood group system is present in almost all D-positive or C-positive red cells but absent from red cells lacking D and C antigens. The differentiation of anti-D and anti-C from anti-G is not necessary for routine transfusion; however, during pregnancy, it is important because anti-G can masquerade as anti-D and anti-C with initial antibody testing. The false presence of anti-D will exclude the patient from receiving anti-D immunoglobulin (RhIG) when the patient actually is a candidate for RhIG prophylaxis. Moreover, patients with positive anti-D or anti-G are at risk of developing hemolytic disease of the fetus and newborn and need close monitoring. Thus, proper identification allows the clinicians to manage patients properly. This case report highlights a rare case of anti-G together with anti-D and anti-C in a pregnant woman. This report disseminates knowledge on identification of anti-G and its importance in pregnant women.